Case Report: Cerebrospinal Fluid Dynamics in the Optic Nerve Subarachnoid Space and the Brain Applying Diffusion Weighted MRI in Patients With Idiopathic Intracranial Hypertension-A Pilot Study.
CSF
MRI
diffusion imaging
idiopathic intracranial hypertension (IIH)
optic nerve (ON)
papilledema
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2022
2022
Historique:
received:
26
01
2022
accepted:
08
03
2022
entrez:
2
5
2022
pubmed:
3
5
2022
medline:
3
5
2022
Statut:
epublish
Résumé
The aim of this study was to examine the cerebrospinal fluid (CSF) flow rates in the subarachnoid space (SAS) of the optic nerve (ON) and the brain in patients with idiopathic intracranial hypertension (IIH) and papilledema (PE) compared to healthy controls by applying non-invasive diffusion-weighted MRI. A retrospective analysis of diffusion-weighted MR images of 5 patients with IIH (10 ONs), mean age: 31 ± 10 years (5 women), and 11 healthy controls (22 ONs, mean age: 60 ± 13 years, 5 women) was performed. The flow velocity flow-range ratio (FRR) between the intracranial cavity and the SAS of the ON was calculated in both groups and then compared. The mean FRR was 0.55 ± 0.08 in patients with IIH and 0.63 ± 0.05 in healthy controls. The difference between patients with IIH and healthy controls was statistically significant ( The CSF flow velocity was decreased in patients with IIH with PE compared to healthy controls. The reduced CSF flow dynamics might be involved in the pathophysiology of PE in IIH and diffusion-weighted MRI can be a useful non-invasive tool to study the CSF flow dynamics within the SAS ON. Idiopathic intracranial hypertension is a neurological disease, where vision loss is the most feared complication of this disorder. The pathophysiology of IIH is not fully understood but is strongly linked to a reduced uptake of CSF into the central dural sinus veins. In this study, we examined the CSF flow rates in the SAS ON and the brain in patients with IIH and PE compared to healthy controls by applying non-invasive diffusion-weighted MRI. Knowing about the flow ratio of CSF may be of clinical relevance for the treatment decisions of IIH. If medical treatment fails, surgical options for lowering the ICP pressure need to be taken into consideration. As the primary goal of treatment is to prevent the loss of vision and visual field, it is important to know whether the communication of CSF between the intracranial CSF and the CSF in the perioptic space is intact. We showed that the CSF flow velocity was decreased in IIH patients with PE compared to healthy controls. The reduced CSF flow might be involved in the pathophysiology of PE in IIH, and diffusion-weighted MRI can be a useful non-invasive tool to study the CSF flow dynamics within the SAS ON.
Identifiants
pubmed: 35493818
doi: 10.3389/fneur.2022.862808
pmc: PMC9051360
doi:
Types de publication
Case Reports
Langues
eng
Pagination
862808Informations de copyright
Copyright © 2022 Berberat, Pircher, Gruber, Lovblad, Remonda and Killer.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Eye (Lond). 2018 Jul;32(7):1164-1167
pubmed: 29527011
J Neuroophthalmol. 2016 Jun;36(2):120-5
pubmed: 26580295
Brain. 2006 Apr;129(Pt 4):1027-30
pubmed: 16504971
Ophthalmology. 1991 Sep;98(9):1449-53
pubmed: 1945323
Arch Neurol. 1991 Apr;48(4):392-9
pubmed: 2012512
Lancet Neurol. 2006 May;5(5):433-42
pubmed: 16632314
Clin Exp Ophthalmol. 2018 Jul;46(5):511-518
pubmed: 29178525
Br J Ophthalmol. 2014 Jun;98(6):721-5
pubmed: 24307714
Int Ophthalmol Clin. 2014 Winter;54(1):95-102
pubmed: 24296374
J Neuroophthalmol. 2017 Jun;37(2):133-139
pubmed: 27930421
Neurology. 2001 Jun 12;56(11):1588-90
pubmed: 11402124
Neurology. 2004 Nov 9;63(9):1737-9
pubmed: 15534272
JAMA. 2014 Apr 23-30;311(16):1641-51
pubmed: 24756514
Front Neurol. 2018 Jun 28;9:506
pubmed: 30002644
JAMA. 1972 Jun 19;220(12):1591-2
pubmed: 5067736
J Clin Neuroophthalmol. 1992 Dec;12(4):238-41
pubmed: 1287047
Indian J Ophthalmol. 2014 Oct;62(10):1015-21
pubmed: 25449938